Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.01SPGP 1.715ZUQ.TO 1.27NVDA 7.15GL 2.43MRK -3.06IEMG 1.96GEV 34.91
Patheon (PTI.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Patheon (PTI.TO)

0.00
-0.00 (0.00%)
6 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
WEAK BUY

Patheon(PTI.TO)

Mar 22, 2002
FMV = $17. There is a strong technical resistance at $14.50/15. Doubt if it will be able to break through.
Photo of Ross HealyRoss HealyUnlock Rating
$12.75

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Mar 21, 2002
A little high. Tends to grow by acquisition which creates debt or good will.
Photo of Bruce CooperBruce CooperUnlock Rating
$12.75

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Mar 15, 2002
Buy around $13. Outsourcing should grow.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$13.00

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Mar 12, 2002
At fair market value now. Might buy at $8.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$13.06

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Mar 08, 2002
Cash flow growth of 30%. New products going through FDA. Volatile. At $12.95 only buy a small bit.
Photo of David DriscollDavid DriscollUnlock Rating
$12.90

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Mar 06, 2002
Grown well. Good long term holding.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$12.76

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Mar 06, 2002
Good outlook in the long term.
Photo of Mike WeirMike WeirUnlock Rating
$12.76

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Patheon(PTI.TO)

Mar 01, 2002
Well run and sector is growing. Buy on weakness of $10.50/11.50.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$12.19

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Patheon(PTI.TO)

Feb 01, 2002
Earnings have been weak. Buy on weakness.
Photo of Robert FloydRobert FloydUnlock Rating
$12.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Jan 18, 2002
A favourite pharmaceutical. Had a good quarter and is at a good price. An excallant hold.
Photo of David BaskinDavid BaskinUnlock Rating
$12.18

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Jan 15, 2002
Has done well.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$12.23

Stock price when the opinion was issued

biotechnologypharmaceutical
WAIT

Patheon(PTI.TO)

Dec 20, 2001
Good outlook for the long term. Numbers are due now.
Photo of Mike WeirMike WeirUnlock Rating
$10.15

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Dec 18, 2001
Good business. Solid management. Reasonable price.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$10.95

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Dec 10, 2001
Good growth. Looks good.
Photo of John ZechnerJohn ZechnerUnlock Rating
$11.85

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Nov 23, 2001
In a good sector and growing well.
Photo of Arthur HeinmaaArthur HeinmaaUnlock Rating
$11.25

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 136 to 150 of 194 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.47$36.78
ET -0.025$19.045
MAIR 0$
RKLB 6.095$108.485
SESG-O 0$

Today's Top Picks

HMP.TO 0.01$9.76
SPGP 1.715$122.105
ZUQ.TO 1.27$108.74
NVDA 7.15$212.34
GL 2.43$169.19

Popular Articles

Latest Sell Signals

PRGO -0.14$10.85
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica